No profile data available.
Endonovo Therapeutics, Inc. (ENDV) is a healthcare company in the various healthcare equipment manufacturing industry, based in Woodland Hills, United States.
It reported revenue of $10,043 for fiscal year 2024, down 92.8% from fiscal year 2023, and net income of -$2.80 million. In Q2 2025 (the quarter ended June 30, 2025) revenue was $0. Its market capitalization was $90,377 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 8, 2026.
, a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.
Endonovo Therapeutics reported $10,043 in revenue for fiscal year 2024, down 92.8% from $140,242 in fiscal year 2023. In Q2 2025 revenue was $0.
$90,377 as of October 8, 2026.
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include CollPlant Biotechnologies Ltd. (CLGN), Therma Bright Inc. (TBRIF), Odyssey Health, Inc. (ODYY).